Free Access
Med Sci (Paris)
Volume 24, Number 1, Janvier 2008
Page(s) 65 - 71
Section M/S revues
Published online 15 January 2008
  1. Wang L, Ho CL, Sun D, et al. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat Cell Biol 2000; 2 : 137–41. [Google Scholar]
  2. Millecamps S, Gowing G, Corti, et al. Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments. J Neurosci 2007; 27 : 4947–56. [Google Scholar]
  3. Reid E, Kloos M, Ashley-Koch A, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002; 71 : 1189–94. [Google Scholar]
  4. Xia CH, Roberts EA, Her LS, et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol 2003; 161 : 55–66. [Google Scholar]
  5. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105 : 587–97. [Google Scholar]
  6. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36 : 449–51. [Google Scholar]
  7. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33 : 455–6. [Google Scholar]
  8. LaMonte BH, Wallace KE, Holloway BA, et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002; 34 : 715–27. [Google Scholar]
  9. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003; 300 : 808–12. [Google Scholar]
  10. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67 : 37–46. [Google Scholar]
  11. Perez-Olle R, Lopez-Toledano MA, Goryunov D, et al. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J Neurochem 2005; 93 : 861–74. [Google Scholar]
  12. Figlewicz DA, Krizus A, Martinoli MG, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3 : 1757–61. [Google Scholar]
  13. Côté F, Collard JF, Julien JP. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene : a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73 : 35–46. [Google Scholar]
  14. Kriz J, Meier J, Julien JP, et al. Altered ionic conductances in axons of transgenic mouse expressing the human neurofilament heavy gene : A mouse model of amyotrophic lateral sclerosis. Exp Neurol 2000; 163 : 414–21. [Google Scholar]
  15. Collard JF, Côté F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995; 375 : 61–4. [Google Scholar]
  16. Gros-Louis F, Lariviere R, Gowing G, et al. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 2004; 279 : 45951–6. [Google Scholar]
  17. Robertson J, Doroudchi MM, Nguyen MD, et al. A neurotoxic peripherin splice variant in a mouse model of ALS. J Cell Biol 2003; 160 : 939–49. [Google Scholar]
  18. Beaulieu JM, Nguyen MD, Julien JP. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol 1999; 147 : 531–44. [Google Scholar]
  19. Millecamps S, Robertson J, Lariviere R, et al. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J Neurochem 2006; 98 : 926–38. [Google Scholar]
  20. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393 : 702–5. [Google Scholar]
  21. Ishihara T, Hong M, Zhang B, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999; 24 : 751–62. [Google Scholar]
  22. Julien JP, Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006; 1762 : 1013–24. [Google Scholar]
  23. Hazan J, Fonknechten N, Mavel D, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 1999; 23 : 296–303. [Google Scholar]
  24. Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93 : 973–83. [Google Scholar]
  25. Errico A, Ballabio A, Rugarli EI. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 2002; 11 : 153–63. [Google Scholar]
  26. Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004; 113 : 231–42. [Google Scholar]
  27. Nishimura AL, Mitne-Neto M, Silva HC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004; 75 : 822–31. [Google Scholar]
  28. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29 : 166–73. [Google Scholar]
  29. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29 : 160–5. [Google Scholar]
  30. Otomo A, Hadano S, Okada T, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet 2003; 12 : 1671–87. [Google Scholar]
  31. Millecamps S, Gentil BJ, Gros-Louis F, et al. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta 2005; 1745 : 84–100. [Google Scholar]
  32. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72 : 722–7. [Google Scholar]
  33. Lai C, Xie C, McCormack SG, et al. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J Neurosci 2006; 26 : 11798–806. [Google Scholar]
  34. Cai H, Lin X, Xie C, et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 2005; 25 : 7567–74. [Google Scholar]
  35. Hadano S, Benn SC, Kakuta S, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet 2006; 15 : 233–50. [Google Scholar]
  36. Devon RS, Orban PC, Gerrow K, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci USA 2006; 103 : 9595–600. [Google Scholar]
  37. Yamanaka K, Miller TM, McAlonis-Downes M, et al. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann Neurol 2006; 60 : 95–104. [Google Scholar]
  38. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999; 2 : 50–6. [Google Scholar]
  39. Zhang B, Tu P, Abtahian F, et al. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 1997; 139 : 1307–15. [Google Scholar]
  40. Kieran D, Hafezparast M, Bohnert S, et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005; 169 : 561–7. [Google Scholar]
  41. Millecamps S, Nicolle D, Ceballos-Picot I, et al. Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA 2001; 98 : 7582–7. [Google Scholar]
  42. Teuchert M, Fischer D, Schwalenstoecker B, et al. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp Neurol 2006; 198 : 271–4. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.